skin diseases, genetic
Showing 1 - 5 of 5
Dermatitis, Atopic, Dermatitis, Eczema Trial in Japan (Lebrikizumab, Placebo, Topical Corticosteroid)
Active, not recruiting
- Dermatitis, Atopic
- +4 more
- Lebrikizumab
- +2 more
-
Ainokawa, Ichikawa-shi, Chiba, Japan
- +36 more
Sep 19, 2022
Dermatitis, Atopic, Dermatitis, Eczema Trial in Hamilton (Benralizumab, Placebo Control)
Completed
- Dermatitis, Atopic
- +9 more
- Benralizumab
- Placebo Control
-
Hamilton, Ontario, CanadaMcMaster Cardio-Respiratory Research Lab
Oct 14, 2021
Dermatitis, Dermatitis, Atopic, Eczema Trial in Worldwide (PF-04965842 100 mg, PF-04965842 200 mg, Placebo)
Completed
- Dermatitis
- +9 more
- PF-04965842 100 mg
- +2 more
-
Birmingham, Alabama
- +234 more
Sep 17, 2021
Dermatitis, Dermatitis, Atopic, Eczema Trial in Worldwide (PF-04965842 100 mg, PF-04965842 200 mg, Dupilumab)
Completed
- Dermatitis
- +9 more
- PF-04965842 100 mg
- +4 more
-
Birmingham, Alabama
- +215 more
Dec 21, 2020
Quality of Life of Treatment of Eczema by Pediatric Generalists
Completed
- Eczema
- +9 more
- Care provided by general pediatrician
- Care provided by pediatric dermatologist
-
New Haven, ConnecticutYale Dermatology Associates
Jan 9, 2018